Page last updated: 2024-09-05

sch 58261 and mrs 1523

sch 58261 has been researched along with mrs 1523 in 1 studies

Compound Research Comparison

Studies
(sch 58261)
Trials
(sch 58261)
Recent Studies (post-2010)
(sch 58261)
Studies
(mrs 1523)
Trials
(mrs 1523)
Recent Studies (post-2010) (mrs 1523)
4601442017

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Gaba, S; Gupta, GD; Monga, V; Patel, R; Saini, A; Singh, G1

Reviews

1 review(s) available for sch 58261 and mrs 1523

ArticleYear
Adenosine receptor antagonists: Recent advances and therapeutic perspective.
    European journal of medicinal chemistry, 2022, Jan-05, Volume: 227

    Topics: Dose-Response Relationship, Drug; Humans; Molecular Structure; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Structure-Activity Relationship

2022